1. Function of Uric Acid Transporters and Their Inhibitors in Hyperuricaemia
   Hao-lu Sun et al, 2021, Front. Pharmacol. CrossRef
2. A review on the fruit components affecting uric acid level and their underlying mechanisms
   Fengmao Zou et al, 2021, J Food Biochem CrossRef
3. Resveratrol ameliorates diabetic kidney injury by reducing lipotoxicity and modulates expression of components of the junctional adhesion molecule-like/sirtuin 1 lipid metabolism pathway
   Wei Gu et al, 2022, European Journal of Pharmacology CrossRef
4. SIRTUIN DEFICIENCY AND THE ADVERSE EFFECTS OF FRUCTOSE AND URIC ACID SYNTHESIS
   Bernardo Rodriguez-Iturbe et al, 2022, American Journal of Physiology-Regulatory, Integrative and Comparative Physiology CrossRef
5. Obese female mice do not exhibit overt hyperuricemia despite hepatic steatosis and impaired glucose tolerance
   Sara E. Lewis et al, 2022, Advances in Redox Research CrossRef
6. A Brief Review of Natural Products with Urate Transporter 1 Inhibition for the Treatment of Hyperuricemia
   Qianghua Yuan et al, 2022, Evidence-Based Complementary and Alternative Medicine CrossRef
7. SLC2A9 rs1014290 Polymorphism is Associated with Prediabetes and Type 2 Diabetes
   Xuemei Zhang et al, 2022, International Journal of Endocrinology CrossRef
8. Effect of Aerobic Treadmill Exercise Regulating Glucose Transporter 9 on Renal Function in Hyperuricemia Rats
   Jiarong LIANG et al, 2022, RM CrossRef
9. A Randomized Trial on Resveratrol Supplement Affecting Lipid Profile and Other Metabolic Markers in Subjects with Dyslipidemia
   Yuqing Zhou et al, 2023, Nutrients CrossRef
10. Mechanistic insights of soluble uric acid-induced insulin resistance: Insulin signaling and beyond
    Wei Yu et al, 2023, Rev Endocr Metab Disord CrossRef
11. TCM and related active compounds in the treatment of gout: the regulation of signaling pathway and urate transporter
    Xin Sun et al, 2023, Front. Pharmacol. CrossRef
12. Bi Xie Fen Qing Yin decoction alleviates potassium oxonate and adenine induced-hyperuricemic nephropathy in mice by modulating gut microbiota and intestinal metabolites
    Xianghao Lin et al, 2024, Biomedicine & Pharmacotherapy CrossRef
13. A Possible Therapeutic Application of the Selective Inhibitor of Urate Transporter 1, Dotinurad, for Metabolic Syndrome, Chronic Kidney Disease, and Cardiovascular Disease
    Hidekatsu Yanai et al, 2024, Cells CrossRef
14. Resveratrol Improves Hyperuricemia and Ameliorates Renal Injury by Modulating the Gut Microbiota
    Yuqing Zhou et al, 2024, Nutrients CrossRef
15. CO-ADMINISTRATION OF RESVERATROL RESCUED LEAD-INDUCED TOXICITY IN DROSOPHILA MELANOGASTER
    R. Abdulazeez et al, 2024, Environmental Toxicology and Pharmacology CrossRef
16. Relationship between Serum Uric Acid Levels and Renal and Carotid Atherosclerotic Lesions in Patients with Type 2 Diabetes Mellitus
    洁 李, 2024, ACM CrossRef
17. Impact of Imperata Cylindrica polysaccharide on liver lipid metabolism disorders caused by hyperuricemia
    Wenchen Yu et al, 2024, International Journal of Biological Macromolecules CrossRef
18. Natural Bioactive Compounds: Emerging Therapies for Hyperuricemia
    Yafei Liu et al, 2024, Am. J. Chin. Med. CrossRef
19. Therapeutic potential and pharmacological mechanisms of Traditional Chinese Medicine in gout treatment
    Jing-wen Guo et al, 2025, Acta Pharmacol Sin CrossRef